« Protiva Biotherapeutics raises $3,500,000
BioVex raises $22,000,000 »

NanoBioDesign Limited raises $1,000,000

July 6, 2007
 VCA Theme: Contract Research Organizations

NanoBioDesign: Imperial Innovations Group plc, the technology commercialisation and investment company (AIM: IVO) and The Capital Fund, the £50 million Regional Venture Capital Fund for London, today announce that together they have invested £500,000 in NanoBioDesign Limited (NBD), a company developing a range of toxicity screening systems to speed up the drug discovery process